Broadcom's Apple Deal Extension Makes AVGO a Strong Buy
Broadcom locked in Apple through 2031, cementing its revenue floor. Here's why the pullback is a buying opportunity.
Broadcom just got a massive vote of confidence, and the market hasn't fully priced it in yet. The Apple partnership extension through 2031 essentially locks in a predictable, high-margin revenue stream for years — turning what was once a renewal risk into a non-issue. That's the kind of de-risking that changes a stock's valuation math entirely.
Shares pulled back hard from the 52-week high of $494.18 down to the $373.90 range — that's a 24% discount from peak. When a compounder gets cheaper and simultaneously safer, you don't overthink it. You buy. The Apple extension didn't just extend a contract; it validated Broadcom's irreplaceable position in the custom silicon and networking ecosystem that Apple depends on.
Read more Prediction Markets Raise Insider Trading Red Flags for Wall Street →
The analyst framing here is important: this isn't a speculative bet on AI hype or a turnaround story. Broadcom is already printing cash. The Apple deal is the floor, and the AI infrastructure buildout — where Broadcom's custom ASICs and networking chips are deeply embedded — is the ceiling. Both legs of the thesis are intact at a lower price than three months ago.
Waiting for a "better" entry on a stock that just eliminated a major risk category is how investors miss the move. The pullback gave a second chance that the market rarely offers cleanly. AVGO isn't cheap on a P/E basis, but compounders with locked-in enterprise relationships rarely are — and they rarely stay at a discount for long once the catalyst gets fully digested by the Street.
Continue reading at Yahoo
